Acknowledgements
Thomas’ NHS, Cancer
CANCER
The trial was funded and sponsored by Cancer Research UK, who collaborated with the academic authors in designing the trial, collated the clinical data, and reviewed the manuscript. The authors acknowledge additional financial support from the UK Department of Health and Cancer Research UK via Experimental Cancer Medicine Centre and NIHR Biomedical Research Centre grants to King’s Health Partners/Guy’s & St Thomas’ NHS Foundation Trust (JS), the University of Cambridge/Cambridge University Hospitals NHS Foundation Trust (BB), University College London/UCL Hospital NHS Trust (RM), and Institute of Cancer Research/Royal Marsden Hospital (UB). We acknowledge the Immune Monitoring Core Facility team at Guy’s and St Thomas’ NHS Foundation Trust (IS-BRC-1215-20006) for flow cytometry facilities, and the Cancer Research UK King’s Health Partners Centre at King’s College London (C604/A25135). The authors would like to thank the patients, their families, the clinical research teams, as well as Sharmistha Ghosh, Amy Pope and Natalie Woodman for their contribution to this study.